Betaliq, Inc.
PrivateLast Round
Series A
Apr 25, 2019
Total Funding Raised
$8M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Betaliq, Inc. is a drug discovery company that develops ophthalmic beta-blockers for the treatment of glaucoma using a water-free drug delivery technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Betaliq, Inc. Comparables
Compare Betaliq, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ocuvex Therapeutics, Inc. | 86% | |
| Qlaris Bio | 80% | |
| Novaliq | 80% |
Betaliq, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 25, 2019 |
Betaliq, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Brookline Capital Markets | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 22, 2026
Monthly visitors increased 86% MoM.
- Apr 25, 2019
$8M round led by Brookline Capital Markets.
Betaliq, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Betaliq, Inc.'s valuation, stock price, and market status.
Is Betaliq, Inc. a public or private company?
Betaliq, Inc. is a private company.
What is the current stock price of Betaliq, Inc.?
Betaliq, Inc. is a private company with no public stock price. Caplight tracks Betaliq, Inc.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Betaliq, Inc. worth (valuation)?
Valuation information for Betaliq, Inc. is not publicly available.
Can I buy Betaliq, Inc. stock?
Betaliq, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Betaliq, Inc.'s last funding round?
Betaliq, Inc.'s most recent funding round was Series A on April 25, 2019.
Who are the main investors in Betaliq, Inc.?
Key investors in Betaliq, Inc. include Brookline Capital Markets.
Will Betaliq, Inc. IPO soon?
No public IPO plans have been announced for Betaliq, Inc..
How can I track Betaliq, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Betaliq, Inc.'s secondary market activity and sign up for updates.